Quick Asked: Viela Bio Contact Us?
Last update: 18 Mar, 2024 
115 Views
Is viela owned by horizon? As a result of the merger, Viela became an indirect wholly owned subsidiary of Horizon.How was the acquisition of viela structured? The acquisition was structured as a two-step cash tender offer for all the issued and outstanding shares of Viela common stock at a price of $53.00per share.What is the viela pipeline? Adds deep, mid-stage biologics pipeline focused primarily on autoimmune and severe inflammatory diseases. The current Viela pipeline includes four therapeutic candidates currently in nine development programs. UPLIZNA Why uplizna for viela? “With its deep, mid-stage biologics pipeline, strong R&D team and on-market medicine UPLIZNA®, Viela is a strong complementary strategic fit with our pipeline, commercial portfolio and therapeutic areas of focus.
Listing Results Viela Bio Contact Us? Question Answers
VIE Stock Viela Bio, Inc. SEC Filings
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells. VIELA
Matthew Hartman Associate Director Viela Bio
(240) 558-0038 Direct Phone (240) ***-**** Get Phone Number HQ Phone (240) 558-0038 Company Viela Bio Matthew Hartman Current Workplace Viela Bio Location 1 Medimmune Way, Gaithersburg, Maryland, 20878, United States Industry Education General, Organizations General, Education, Description Discover more about Viela Bio
Viela Bio IPOScoop
Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums), is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as ...
Viela Bio Email Format vielabio.com Emails
Viela Bio uses 1 email formats: 1. last [email protected] (100.0%). Enter a name to find & verify an email >>> Rocketreach finds email, phone & social media for 450M+ professionals.
Viela Bio, Inc. in Bismarck, ND Company Info & Reviews
Viela Bio, Inc. is a North Dakota Foreign Corporation - Business filed On July 12, 2019. The company's filing status is listed as Active and its File Number is 0002850623. The Registered Agent on file for this company is C T Corporation System and is located at 120 W Sweet Ave, Bismarck, ND 58504-5566.
Aaron Ren Viela Bio Email Id Direct Dial
Aaron Ren is serving as Business Development, Operations in the Viela Bio is an active company headquartered in Maryland in the states of .The Viela Bio office address is located at , United States.The company comes under industries.
TrueBinding, Inc. Biocom California
Contact us here: [email protected] About TrueBinding, Inc. Biotech Company TrueBinding Inc. is a biotech startup located in Menlo Park, California, developing antibody therapeutics to treat metabolic diseases and cancer, based on our proprietary TrueBinding platform .
Expanded Access Navigator
323-221-7818 323-221-7818 [email protected] 5 business days Additional Information VelosBio Inc. EA Webpage [email protected] 5 business days Additional Information Venatorx Pharmaceuticals, Inc. EA Webpage Clinicaltrials.gov (610) 644-8935 [email protected] Up to 24 hours Additional Information Viela Bio EA Webpage Clinicaltrials.gov (240) 558-0038
Viela Bio, Inc. in Salt Lake City, UT Company Info & Reviews
Viela Bio, Inc. is an Utah Corporation - Foreign - Profit filed On June 26, 2019. The company's filing status is listed as Active and its File Number is 11358496-0143. The Registered Agent on file for this company is CT Corporation System and is located at 15 W South Temple Ste 600, Salt Lake City, UT 84101.
Viela Bio Crunchbase Company Profile & Funding
Contact Email [email protected]. Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company’s portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity
Bill Ragatz's email & phone Viela Bio's Senior Vice
Scouring the web at all hours of the night wasn't gonna cut it. RocketReach has given us a great place to start. Our workflow has solid direction now - we have a process in place the begins with RocketReach and ends with huge contact lists for our sales team..it probably saves Feedtrail about 3 months of work in terms of lead gathering.
ArriVent – Accelerating the Global Development of
Dr. Yao is an accomplished executive and scientist with more than 25 years of experience in the biotechnology and pharmaceutical industry. Most recently, he served as Chairman and CEO of Viela Bio, which he co-founded in 2018. In 2021, Viela Bio was acquired by Horizon Therapeutics for $3 billion.
Viela Bio, Inc. Company Profile Gaithersburg, MD
(240) 558-0038 Phone (240) 558-0038 Company Description Viela Bio, Inc. is located in Gaithersburg, MD, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Viela Bio, Inc. has 137 total employees across all of its locations and generates $11.65 million in sales (USD). There are 27 companies in the Viela Bio, Inc. corporate family.
Horizon Therapeutics plc Completes Acquisition of Viela
DUBLIN--(BUSINESS WIRE)--Mar. 15, 2021-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has completed the acquisition of Viela Bio, Inc. (Nasdaq: VIE) (“Viela”). “The Viela acquisition provides multiple opportunities to drive long-term growth and solidify our future as an innovation-driven biotech company,” said Tim Walbert, chairman, ...
Viela Bio MIDORA STAT Research
Viela Bio - MIDORA. A phase 2, randomized, double-blind, placebo-controlled, mechanistic insight and dosage optimization study of the efficacy and safety of VIB4920 in patients with rheumatoid arthritis (RA) Info at ClinicalTrials.gov. Benefits.
Viela Bio Overview, News & Competitors ZoomInfo.com
(240) 558-0038 Divestment of Viela shareholding completed 16 March 2021 07:05 GMT Divestment of Viela shareholding completed AstraZeneca has completed the divestment of its 26.7% ownership in Viela Bio, Inc. (Viela), as part of the proposed acquisition of Viela by Horizon Therapeutics plc.
Horizon Therapeutics
News. 12/16/2021 Alpine Immune Sciences and Horizon Therapeutics plc Announce Exclusive License and Collaboration Agreement to Develop Novel Protein-Based Therapies for Autoimmune and Inflammatory Diseases 12/02/2021 Horizon Therapeutics plc Makes $100,000 Seed Donation to Support Fundraising Efforts to Renovate Emmett Till’s ...